Seda Kahraman

7PUBLICATIONS
20CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 25, 2025
Impact of HIF-1α, LOX and ITGA5 Synergistic Interaction in the Tumor Microenvironment on Colorectal Cancer Prognosis.

Hayriye Tatlı Doğan, Mehmet Doğan, Seda Kahraman

|May 03, 2023
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.

Seda Kahraman, Enes Erul, Mustafa Seyyar

|Aug 02, 2022
Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.

Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici

|Jan 21, 2022
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?

Seda Kahraman, Ulviye Esra Erbas, Bulent Yalcin

|Jul 21, 2021
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer.

Seda Kahraman, Suayib Yalcin

Pageof 2